Home » Topics » Regulatory

Regulatory
RSS

Forest files for FDA approval of Synapton

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Fixed-dose trandolapril/verapamil combination now available in U.K.

Nov. 25, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...